GMV 0.00% 3.9¢ g medical innovations holdings limited

GMV - Fundamental Analysis, page-2

  1. 1,584 Posts.
    lightbulb Created with Sketch. 1766
    @ Tiglath - g'day!! I'm loving the new threads - like a new start for GMV

    Towards the end of October 2019, I posted the below feedback about GMV's last 4C , and it probably has some relevance in this thread.

    Be interesting to see if this "trend" of reducing expenses & less overall cash outflows continues in the upcoming 4C?

    Post from End of October 2019

    Really solid 4C - the cash receipts were slightly lower than I expected ($1,478K versus my estimate of $1,600K), but the expenses were way down on my estimates ($2,388K versus estimate of $3,400K).

    The last 4 x cash outgoings (total expenses) on the 4C's have been approximately:

    31/12/18 $4,056k
    31/3/19 $3,635k
    30/6/19 $3,555K
    30/9/19 $2,388k

    There was a huge decrease in cash outgoings in the last quarter - so they are obviously "tightening their belts" due to the delay in the approvals.

    Cash burn of less than $1.0m this quarter (when it has always been from $2.2m to $2.7m) - reducing the nett cash outgoings will help GMV a lot going forward.
 
watchlist Created with Sketch. Add GMV (ASX) to my watchlist

Currently unlisted public company.

arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.